These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 28138303)

  • 1. Amino Acid Profiles of Serum and Urine in Search for Prostate Cancer Biomarkers: a Pilot Study.
    Dereziński P; Klupczynska A; Sawicki W; Pałka JA; Kokot ZJ
    Int J Med Sci; 2017; 14(1):1-12. PubMed ID: 28138303
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prospective serum metabolomic profiling of lethal prostate cancer.
    Huang J; Mondul AM; Weinstein SJ; Derkach A; Moore SC; Sampson JN; Albanes D
    Int J Cancer; 2019 Dec; 145(12):3231-3243. PubMed ID: 30779128
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Determination of amino acids in urine of patients with prostate cancer and benign prostate growth.
    Sroka WD; Boughton BA; Reddy P; Roessner U; Słupski P; Jarzemski P; Dąbrowska A; Markuszewski MJ; Marszałł MP
    Eur J Cancer Prev; 2017 Mar; 26(2):131-134. PubMed ID: 27222937
    [TBL] [Abstract][Full Text] [Related]  

  • 4. LC-MS analysis of chiral amino acids in human urine reveals D-amino acids as potential biomarkers for colorectal cancer.
    Deng W; Ye C; Wang W; Huang R; Guo C; Pan Y; Sun C
    J Chromatogr B Analyt Technol Biomed Life Sci; 2024 Sep; 1245():124270. PubMed ID: 39121519
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma metabolomic profile in prostatic intraepithelial neoplasia and prostate cancer and associations with the prostate-specific antigen and the Gleason score.
    Markin PA; Brito A; Moskaleva N; Lartsova EV; Shpot YV; Lerner YV; Mikhajlov VY; Potoldykova NV; Enikeev DV; La Frano MR; Appolonova SA
    Metabolomics; 2020 Jun; 16(7):74. PubMed ID: 32556743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative urinary proteomics using stable isotope labelling by peptide dimethylation in patients with prostate cancer.
    Li C; Zang T; Wrobel K; Huang JT; Nabi G
    Anal Bioanal Chem; 2015 May; 407(12):3393-404. PubMed ID: 25724369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Urine metabolic fingerprinting using LC-MS and GC-MS reveals metabolite changes in prostate cancer: A pilot study.
    Struck-Lewicka W; Kordalewska M; Bujak R; Yumba Mpanga A; Markuszewski M; Jacyna J; Matuszewski M; Kaliszan R; Markuszewski MJ
    J Pharm Biomed Anal; 2015; 111():351-61. PubMed ID: 25684700
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The decrease of some serum free amino acids can predict breast cancer diagnosis and progression.
    Eniu DT; Romanciuc F; Moraru C; Goidescu I; Eniu D; Staicu A; Rachieriu C; Buiga R; Socaciu C
    Scand J Clin Lab Invest; 2019; 79(1-2):17-24. PubMed ID: 30880483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evaluation of serum amino acid profiles' utility in non-small cell lung cancer detection in Polish population.
    Klupczynska A; Dereziński P; Dyszkiewicz W; Pawlak K; Kasprzyk M; Kokot ZJ
    Lung Cancer; 2016 Oct; 100():71-76. PubMed ID: 27597283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A study of low-molecular-weight organic acid urinary profiles in prostate cancer by a new liquid chromatography-tandem mass spectrometry method.
    Klupczynska A; Plewa S; Sytek N; Sawicki W; Dereziński P; Matysiak J; Kokot ZJ
    J Pharm Biomed Anal; 2018 Sep; 159():229-236. PubMed ID: 29990890
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urinary estrogen metabolites and prostate cancer risk: a pilot study.
    Kosti O; Xu X; Veenstra TD; Hsing AW; Chu LW; Goldman L; Bebu I; Collins S; Dritschilo A; Lynch JH; Goldman R
    Prostate; 2011 Apr; 71(5):507-16. PubMed ID: 20886539
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Metabolomic Profiling of Extracellular Vesicles and Alternative Normalization Methods Reveal Enriched Metabolites and Strategies to Study Prostate Cancer-Related Changes.
    Puhka M; Takatalo M; Nordberg ME; Valkonen S; Nandania J; Aatonen M; Yliperttula M; Laitinen S; Velagapudi V; Mirtti T; Kallioniemi O; Rannikko A; Siljander PR; Af Hällström TM
    Theranostics; 2017; 7(16):3824-3841. PubMed ID: 29109780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low serum dehydroepiandrosterone examined by liquid chromatography-tandem mass spectrometry correlates with poor prognosis in hormone-naïve prostate cancer.
    Miyoshi Y; Uemura H; Umemoto S; Sakamaki K; Taguri M; Suzuki K; Shibata Y; Masumori N; Ichikawa T; Mizokami A; Sugimura Y; Nonomura N; Sakai H; Honma S; Harada M; Kubota Y
    Prostate; 2016 Mar; 76(4):376-82. PubMed ID: 26616365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. NMR-based metabolomics analysis identifies discriminatory metabolic disturbances in tissue and biofluid samples for progressive prostate cancer.
    Zheng H; Dong B; Ning J; Shao X; Zhao L; Jiang Q; Ji H; Cai A; Xue W; Gao H
    Clin Chim Acta; 2020 Feb; 501():241-251. PubMed ID: 31758937
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated ionization approach for RRLC-MS/MS-based metabonomics: finding potential biomarkers for lung cancer.
    An Z; Chen Y; Zhang R; Song Y; Sun J; He J; Bai J; Dong L; Zhan Q; Abliz Z
    J Proteome Res; 2010 Aug; 9(8):4071-81. PubMed ID: 20560663
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Quantification of candidate prostate cancer metabolite biomarkers in urine using dispersive derivatization liquid-liquid microextraction followed by gas and liquid chromatography-mass spectrometry.
    Shamsipur M; Naseri MT; Babri M
    J Pharm Biomed Anal; 2013; 81-82():65-75. PubMed ID: 23624158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. An analysis of urine and serum amino acids in critically ill patients upon admission by means of targeted LC-MS/MS: a preliminary study.
    Mierzchała-Pasierb M; Lipińska-Gediga M; Fleszar MG; Lewandowski Ł; Serek P; Płaczkowska S; Krzystek-Korpacka M
    Sci Rep; 2021 Oct; 11(1):19977. PubMed ID: 34620961
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteomic analysis of voided urine after prostatic massage from patients with prostate cancer: a pilot study.
    Rehman I; Azzouzi AR; Catto JW; Allen S; Cross SS; Feeley K; Meuth M; Hamdy FC
    Urology; 2004 Dec; 64(6):1238-43. PubMed ID: 15596215
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tyrosine and tryptophan in urine as biomarkers for prostate cancer: A validation study.
    Nasimi H; Madsen JS; Zedan AH; Schmedes AV; Malmendal A; Osther PJS; Alatraktchi FA
    J Pharm Biomed Anal; 2024 Nov; 250():116398. PubMed ID: 39121538
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Elevated Metabolites of Steroidogenesis and Amino Acid Metabolism in Preadolescent Female Children With High Urinary Bisphenol A Levels: A High-Resolution Metabolomics Study.
    Khan A; Park H; Lee HA; Park B; Gwak HS; Lee HR; Jee SH; Park YH
    Toxicol Sci; 2017 Dec; 160(2):371-385. PubMed ID: 28973422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.